The recently reported reductions in the incidence of post-operative venous
thromboembolism (VIE) are related to the widespread use of prophylactic ant
icoagulants, Many uncertainties remain with regard to the most effective wa
ys to use thromboprophylaxis, however. The trend towards shorter hospital s
tays means that patients may receive less than the recommended 7-10 days of
prophylaxis. Prolonged periods of thromboprophylaxis may be beneficial for
patients at high risk of post-operative VTE, such as those undergoing majo
r orthopaedic surgery, The relative rarity of symptomatic deep vein thrombo
sis and pulmonary embolism means that very large patient populations are re
quired for studies that rely on clinical endpoints, but studies using venog
raphic endpoints have shown 28-35 days of prophylaxis with low-molecular-we
ight heparin to be more effective than 10-14 days. Other factors that may i
nfluence the efficacy of thromboprophylaxis include the timing of the first
injection and the choice of agent. Copyright (C) 1999 S. Karger AG, Basel.